Kenya - English - Pharmacy and Poisons Board

laso healthcare pvt. ltd. old no. 1/ 90, new no. 5/ 92, pillayar koil - imipenem and cilastatin for injection (sterile) - powder for injection - sterile imipenem usp eq. to anhydrous imipenem… - imipenem and enzyme inhibitor

Kenya - English - Pharmacy and Poisons Board

imipenem hydrate / cilastatin sodium - powder for solution for injection/infusion - each vial contains imipenem (as hydrate) 500mg… - imipenem and enzyme inhibitor

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

belmedpreparaty rue - imipenem (imipenem monohydrate), cilastatin (cilastatin sodium) - powder for solution for infusion - 500mg+ 500mg

Malta - English - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - powder for solution for infusion - imipenem 500 mg cilastatin 500 mg - antibacterials for systemic use

Kenya - English - Pharmacy and Poisons Board

national pharmacy ltd p.o box 17843-00500 nairobi , kenya - each vial contains: imipenem (sterile) usp….500… - injection - each vial contains: imipenem (sterile) usp….500… - imipenem and enzyme inhibitor

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - cilastatin sodium 530.7mg equivalent to 500 mg cilastatin; imipenem monohydrate 530.1mg equivalent to 500 mg imipenem - powder for injection - 500mg/500mg - active: cilastatin sodium 530.7mg equivalent to 500 mg cilastatin imipenem monohydrate 530.1mg equivalent to 500 mg imipenem excipient: sodium bicarbonate - indicated for the treatment of the following infections due to susceptible organisms: · intra-abdominal infections · lower respiratory tract infections · gynaecological infections · septicaemia · genitourinary tract infections · bone and joint infections · skin and soft tissue infections · endocarditis indicated for the treatment of mixed infections caused by susceptible strains of aerobic and anaerobic bacteria. the majority of these mixed infections are associated with contamination by faecal flora or flora originating from the vagina, skin and mouth. in these mixed infections, bacteroides fragilis is the most commonly encountered anaerobic pathogen and is usually resistant to aminoglycosides, ephalosporins and penicillins. however, bacteroides fragilis is usually susceptible to imipenem and cilastatin combination. imipenem and cilastatin combination has demonstrated efficacy against many infections caused by aerobic and anaerobic gram-positive and gram-negative bacteria resistant to the cephalosporins, including cefazolin, cefoperazone, cephalothin, cefoxitin, cefotaxime, moxalactam, cefamandole, ceftazidime and ceftriaxone. similarly, many infections caused by organisms resistant to aminoglycosides (gentamicin, amikacin, tobramycin) and/or penicillins (ampicillin, carbenicillin, penicillin-g, ticarcillin, piperacillin, azlocillin, mezlocillin) responded to treatment imipenem and cilastatin. imipenem+cilastatin rbx is not indicated for the treatment of meningitis.

Ireland - English - HPRA (Health Products Regulatory Authority)

hikma farmacêutica (portugal) s.a. - imipenem; cilastatin - powder for solution for infusion - 500 mg/500 milligram(s) - carbapenems; imipenem and enzyme inhibitor

Ireland - English - HPRA (Health Products Regulatory Authority)

merck sharp & dohme ireland (human health) limited - imipenem monohydrate; cilastatin sodium - powder for solution for infusion - 500mg/500 milligram(s) - carbapenems; imipenem and enzyme inhibitor